Keywords
Neurology ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

- 2/1/20 - 1 form, 16 itemgroups, 156 items, 1 language
Itemgroups: Date of visit, Assessment Date, Adverse Event; Concomitant Agent; Evaluation, Repeat, Liver, Adverse Event, Non-serious Adverse Event, Serious Adverse Event, Concomitant Agent, Laboratory Procedures, Vital signs, Pharmacokinetic aspect, Blood, Repeat, Pulmonary function tests, Repeat, Holter Electrocardiography, Repeat, Holter Electrocardiography, Abnormality, Repeat, Telemetry, Repeat, Telemetry, Abnormality, Repeat, 12 lead ECG, Abnormality, Repeat, 12 lead ECG
- 1/9/20 - 1 form, 21 itemgroups, 78 items, 1 language
Itemgroups: Administrative, Liver Events, Alcohol intake at onset of liver event, Medical Conditions at onset of liver event, Drug related liver disease conditions, Other Liver disease conditions, Other medical conditions, Pharmacokinetics, Liver Imaging, Liver biopsy, Liver architecture, Description of liver cells or hepatocytes, Liver cell or hepatocyte inclusions or vaculoles, Hepatocyte or liver cell nuclear abnormalities, Liver or lobular infiltrates, Portal tract inflammation, Bile Ducts, Portal Veins, Liver infections, Parasites or Ova, Histologic staining or additinoal studies obtained
- 1/9/20 - 1 form, 19 itemgroups, 77 items, 1 language
Itemgroups: Administrative, Adverse Events, Adverse Event - Intensity Changes, Serious Adverse Event, Randomisation, Adverse Event - Seriousness, Relevant Concomitant/Treatment Medications, Lab Sequence Number, Relevant Diagnostic Results, Adverse Events - Rechallenge, General Narrative Comments, Possible suicidality-related adverse event - Section 1, Possible suicidality-related adverse event - Section 2, Possible suicidality-related adverse event - Section 3 , Possible suicidality-related adverse event - Section 4 , Possible suicidality-related adverse event - Section 5 , Possible suicidality-related adverse event - Section 6 , Possible suicidality-related adverse event - Section 7 , Possible suicidality-related adverse event - Section 8